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ABSTRACT Dihydropyridine receptors were purified from rabbit skeletal muscle transverse tubule membranes and
incorporated into planar lipid bilayers. Calcium channels from both the purified dihydropyridine receptor preparation
and the intact transverse tubule membranes exhibited two sizes of unitary currents, corresponding to conductances of
7 ± 1 pS and 16 ± 3 pS in 80 mM BaCl2. Both conductance levels were selective for divalent cations over monovalent
cations and anions. Cadmium, an inorganic calcium channel blocker, reduced the single channel conductance of
calcium channels from the purified preparation. The organic calcium channel antagonist nifedipine reduced the
probability of a single channel being open with little effect on the single channel conductance. The presence of two
conductance levels in both the intact transverse tubule membranes and the purified dihydropyridine receptor
preparation suggests that the calcium channel may have multiple conductance levels or that multiple types of calcium
channels with closely related structures are present in transverse tubule membranes.
INTRODUCTION
The dihydropyridines (DHPs) as exemplified by nitrendi-
pine and nifedipine have been shown to inhibit calcium
influx through many types of voltage-dependent calcium
channels (for review see reference 30). High affinity
binding sites for these compounds have been identified in a
variety of tissues (34). Although there is substantial evi-
dence that DHPs modulate calcium channel function by
interacting directly with the calcium channel molecule or a
closely associated protein, it is not yet clear whether the
high affinity DHP binding sites actually represent DHP-
sensitive calcium channels. The picture has been compli-
cated by the observations that a large fraction of the
DHP-binding sites in skeletal muscle do not appear to be
functional calcium channels (26, 31).
We sought to clarify the relationship between the DHP
receptor and calcium channels still further by purifying the
receptor from skeletal muscle transverse tubule (T-tubule)
membranes, then incorporating the purified receptor into
planar lipid bilayers. In this study we show that purified
DHP receptor preparations reconstituted into planar lipid
bilayers exhibit two divalent cation-selective conductance
levels of 7 and 16 pS, similar in single channel conductance
to calcium channels reported in a variety of intact prepara-
The present address of Drs. Worley and Nelson is Department of
Pharmacology, Given Building, University of Vermont, College of Medi-
cine, Burlington, VT 05405.
Please address all correspondence to Jane A. Talvenheimo, Department
of Pharmacology R-189, University of Miami School of Medicine, P.O.
Box 016189, Miami, FL 33101.
tions (21, 23, 35). The larger conductance level is sensitive
to DHPs and appears to be very similar to the calcium
channel described by Flockerzi et al. (15), and to the
calcium channel identified in intact rat T-tubule mem-
branes by Affolter and Coronado (1). The smaller conduc-
tance level may be similar to the 10.6 pS T-tubule calcium
channel described by Rosenberg et al. (27). It is not known
whether these two conductance levels represent two dif-
ferent calcium channel types or whether they represent two
conductance levels of a single calcium channel molecule.
However, the presence of at least two calcium channel
conductance levels in both intact T-tubule membranes and
highly purified DHP receptor preparations suggests that
the molecular structures underlying these conductance
levels may be very closely related.
A preliminary account of this work was presented to the
Society for General Physiology (32).
METHODS AND MATERIALS
Transverse Tubule Membrane Preparation
T-tubule membranes were prepared from rabbit back muscle according to
the method of Glossmann et al. (16) in the presence of protease inhibitors
(1 mM iodoacetamide, 1 ,M Pepstatin A, and 0.1 mM phenylmethylsul-
fonyl fluoride). Membranes were suspended in 0.25 M sucrose, 50 mM
Tris-HCI, pH 7.4, at a protein concentration of 5-10 mg/ml, and stored
at -700C. These preparations contained 15-90 pmol of [3H]PN200-1 10
binding sites per mg of membrane protein.
Purification of the DHP Receptor
The DHP receptor was purified from T-tubule membranes as described
by Curtis and Catterall (12). The following modifications were intro-
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duced into this procedure: (a) To improve the yield of labeled DHP
receptor, the receptor was labeled with [3H]PN200-1 10 after rather than
before solubilization; (b) The DHP receptor was eluted from the first
wheat germ agglutinin (WGA)-Sepharose column in a low ionic strength
buffer and applied directly to DEAE-Sephadex without further dilution;
and (c) Diltiazem, a calcium channel antagonist that would interfere with
the detection of functional reconstituted calcium channels, was not
included in any of the solutions used for purification. Membranes were
solubilized in 1% digitonin, 150 mM NaCl, 25 mM Tris-HCl, pH 7.4, 1
mM CaCl2, at a final protein concentration of 2.5 mg/ml. After
centrifugation at 175,000 g for 30 min to remove insoluble material, the
soluble receptor was labeled with [3H]PN200-11O at a total concentration
of 2.5 nM, which was sufficient to label 5-10% of the total receptor. The
labeled receptor was absorbed to WGA-Sepharose washed with 150 mM
NaCl, 25 mM Tris-HCl, pH 7.4, 1 mM CaCl2, then washed with 20 mM
NaCl, 25 mM Tris-HCl, pH 7.4,0.1 M sucrose, 1 mM CaCl2, and finally
eluted with 100 mM N-acetylglucosamine, 20 mM NaCl, 25 mM
Tris-HCI, pH 7.4, 1 mM CaCl2. The eluted receptor, detected by bound
[3H]PN200-1 10, was applied directly to DEAE-Sephadex equilibrated in
20 mM NaCl, 25 mM Tris-HCl, pH 7.4, 1 mM CaCI2, and eluted with a
linear 20-200 mM NaCl gradient. The peak receptor fractions from this
step were concentrated by a second WGA-Sepharose step and further
purified by sedimentation on linear 5-20% sucrose gradients (in 150 mM
NaCl, 25 mM Tris-HCl, pH 7.4, 1 mM CaCl2), as described by Curtis
and Catterall (12). All solutions used for the purification contained 0.1%
digitonin, 1 mM iodoacetamide, 0.1 mM phenylmethylsulfonyl fluoride,
and 1 uM Pepstatin A.
[3H]PN200-1 10 Binding Assays
[3H]PN200-1 10 binding to intact T-tubule membranes was measured by
rapid filtration through GF/C filters (Whatman Inc., Clifton, NJ), as
previously described by Curtis and Catterall (11). Membrane samples
containing a total of 2.5,g protein in a volume of 0.5 ml, binding solution
(150 mM NaCl, 25 mM Tris-HCl, pH 7.4, 1 mM CaCl2) were incubated
for 90 min at 40C with the desired final concentration of [3H]PN200-110.
Nonspecific binding was measured in the presence of 1 gM unlabeled
nifedipine.
Reversible [3H]PN200-1 1O binding to the soluble DHP receptor was
measured using a Sephadex G-50 centrifugation assay. Samples of the
soluble receptor (0.1-1.25 MAg of protein) were incubated in 0.25 ml of
binding solution containing 0.05% digitonin and the desired final concen-
tration of [3H] PN200- 10 for 90 min at 40C. Bound ligand was measured
by centrifuging 200-Ml aliquots of the samples through 2-ml Sephadex
G-50 columns that had been equilibrated with binding solution (no
digitonin), exactly as described previously (9). Protein recovery from the
columns averaged 83%. Nonspecific binding was determined in the
presence of 1 MM unlabeled nifedipine. The Kd and B,,, for [3H]PN200-
110 binding to both intact membranes and the digitonin-solubilized
receptor were determined by a Scatchard transformation of the data. The
Kd for [3H]PN200-1 10 binding to intact T-tubule membranes ranged
from 0.5 to 2.0 nM and was not significantly changed by solubilization of
the binding site (see Fig. 1).
Specific DHP Binding Activity of Purified
Receptor Preparations
The specific binding activity of the purified receptor was determined by
two methods: (a) measuring reversible [3H]PN200-1 10 binding to the
soluble receptor directly, as described above, and (b) estimating the
amount of receptor present in purified samples by measuring the amount
of prelabeled receptor and correcting for [3H]PN200-1 10 dissociation as
described by Curtis and Catterall (12). The results of these two methods
agree quite well for receptor purified through a single step, but for
receptor purified through all four steps, the second method yields higher
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FIGURE 1 Specific [3H]PN200-110 binding to intact T-tubule mem-
branes and to digitonin-solubilized DHP receptor. (A) Intact T-tubule
membranes (0.0025 mg protein in 0.5 ml final vol) were incubated for 90
min at 40C in a solution containing 150mM NaCl, 25 mM Tris-HCI, pH
7.4, 1 mM CaCl2, and the indicated final concentration of [3H]PN200-
110. Total binding was measured by filtration through Whatman GF/C
filters. Specific binding was calculated by subtracting the nonspecific
binding measured in the presence of 1 gM nifedipine from total binding.
Data shown are duplicate samples from a single experiment. (B) Soluble
DHP receptor was prepared as described in Methods from the same
membranes used in A. The soluble DHP receptor (0.006 mg in 0.5 ml
final vol) was incubated for 90 min at 40C in a solution containing 150
mM NaCl, 25 mM Tris-HCl, pH 7.4, 1 mM CaC12, 0.05% (wt/vol)
digitonin, and the indicated final concentration of [3H]PN200-1 10. Total
binding was measured by the Sephadex G-50 column centrifugation
assay. Specific binding to duplicate samples are plotted for a single
experiment. Curves were fit to a single binding site by computer analysis.
values for the specific activity than the direct assay of reversible binding
(3,400 pmol/mg estimated from pre-bound [3H]PN200-1 10 compared
with 2,500 pmol/mg measured in the reversible binding assay). This
result suggests that some of the receptor is denatured during purification.
For the experiments described here, DHP receptor purified to a specific
activity of 1,800-2,500 pmol/mg, determined by reversible binding assay,
was used.
Protein Assay
Protein concentrations were measured using a Coomassie Blue dye
binding assay (7).
SDS PAGE
Samples were lyophilized and analyzed on discontinuous polyacrylamide
gels composed of a 4% stacking gel and a running gel containing a linear
5-15% acrylamide gradient (18). Gels were silver-stained according to
Oakley et al. (24).
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Reconstitution of the Purified DHP
Receptor into Phospholipid Vesicles
Purified DHP receptor was incorporated into phospholipid vesicles by
adding egg phosphatidylcholine (Sigma Chemical Co., St. Louis, MO)
and bovine brain phosphatidylethanolamine (Sigma Chemical Co.) dis-
solved in Triton X-100 to the purified soluble receptor. The final
concentrations of lipid, protein, and detergents were: 0.2% (wt/vol)
phosphatidylcholine, 0.13% (wt/vol) phosphatidylethanolamine, 0.005
mg/ml protein, 1.67% (wt/vol) Triton X-100, and 0.083% (wt/vol)
digitonin in 150 mM NaCI, 25 mM Tris-HCI, pH 7.4, 1 mM CaCl2, 0.4
M sucrose. To form lipid vesicles, the detergents were removed from the
sample by adsorption to polystyrene beads (0.4 vol of Amberlite XAD-2
polystyrene beads [Sigma Chemical Co.] added to I vol of receptor/lipid
sample), as described by Talvenheimo et al. (33).
Incorporation of Calcium Channels
into Planar Lipid Bilayers
Planar lipid bilayers were formed from a lipid solution in decane (33
mg/ml bovine brain phosphatidylethanolamine, 26 mg/ml bovine brain
phosphatidylserine) (Avanti Polar Lipids, Birmingham, AL) across a
100-250-,um-diam hole in a Lexan partition (General Electric Co.,
Atlanta, GA) separating two experimental chambers, as described by
Nelson et al. (20). Calcium channels from intact T-tubule membranes or
reconstituted DHP receptor samples were incorporated into preformed
planar lipid bilayers by adding the sample to one side of the bilayer to a
final protein concentration of -0.01 mg/ml (intact membranes) or 0.01
Mg/ml solution (purified DHP receptor).
Electrical Recording
Current fluctuations across the bilayer were measured and command
voltages were applied using a pair of Ag/AgCl electrodes, exactly as
described previously (19, 20). The side of the bilayer to which protein is
added is designated the cis side, the opposite side is defined as the trans
side. The voltages in these experiments are defined as cis minus trans,
with the trans side held at virtual ground. Currents through single
calcium channels were recorded continuously on an FM or VCR tape
recorder, then played back through an eight-pole Bessel filter (Frequency
Devices, Haverhill, MA) at 50-100 Hz for analysis on an AT&T PC6300
computer. The bilayer conductance before the addition of protein was
always <10 pS.
Experimental Conditions
To compare single channel conductances of "purified" calcium channels
in the bilayer to published work on single calcium channels in membrane
patches or in bilayers, a large barium gradient was imposed across the
bilayer using 80 mM BaCI2 on the cis side and 50 mM NaCl on the trans
side. At 0 mV divalent cation-selective channels are readily detected as
positive current fluctuations carried by Ba ions moving from cis to trans.
In some experiments (see figure legends for details) symmetrical BaCl2
solutions were used. All solutions contained 10 mM Hepes, adjusted to
pH 7 with Ba(OH)2 or NaOH. In addition, the DHP agonist (29) Bay K
8644 (1-10 ,M) was present in most experiments, unless noted otherwise,
on both sides of the bilayer. Bay K 8644 was kindly provided by Dr. A.
Scriabine (Miles Laboratories Inc., Naperville, IL).
RESULTS
Measurement of Reversible DHP Binding
to the Digitonin-solubilized DHP Receptor
DHP binding to intact T-tubule membranes and to the
unpurified soluble DHP receptor was remarkably similar.
Fig. 1 compares specific [3H]PN200-110 binding to intact
T-tubule membranes (A) and to the unpurified solubilized
receptor (B). The intact membranes bound 92 pmol
[3H]PN200-1 10 per mg protein with a dissociation con-
stant (KD) of 1.18 nM. The membrane preparation was
solubilized and [3H]PN200-110 binding to the soluble
receptor was measured as described in Methods. The
soluble receptor bound 77 pmol [3H]PN200-110 per mg
with a KD of 0.73 nM. The similarity of the binding
parameters for intact membranes and for the solubilized
DHP receptor indicates that the initial solubilization step
does not alter the affinity of the binding site for
[3H]PN200-110, nor does it selectivity solubilize DHP
receptors from the membrane. Similar results were
obtained for five separate experiments in which the KD for
[3H]PN200-1 10 binding to the soluble receptor was com-
pared with that of the starting membrane preparation. The
average Bm. and KD for [3H]PN200- 110 binding to the
intact T-tubule membranes used for receptor purification
were 40 pmol/mg and 1.1 nM, respectively. The average
B.X and KD for the DHP receptor solubilized from these
membranes were 42 pmol/mg and 1.4 nM, respectively.
Purification and Subunit Composition
of the DHP Receptor
The DHP receptor was purified after solubilizing T-tubule
membranes in digitonin. The soluble receptor was labeled
with [3H]PN200- 110, chromatographed on WGA-Sepha-
rose and DEAE-Sephadex, concentrated on WGA-Sepha-
rose, and sedimented on a 5-20% sucrose gradient (see
Methods for details). The specific [3H]PN200-1 10 binding
activity of the purified receptor, determined from measure-
ment of reversible [3H]PN200-1 10 binding, varied from
1,800 to 2,500 pmol/mg. The maximum theoretical spe-
cific activity of the skeletal muscle DHP receptor has been
estimated to be 4,370 pmol DHP bound per mg protein,
assuming that 1 mol of DHP binds to 1 mol of receptor,
and that the molecular mass of the DHP binding site is 210
kD, as suggested by target size analysis (22). A specific
activity of 2,500 pmol/mg therefore corresponds to a
receptor preparation that is 60% pure with-respect to DHP
binding activity. The KD for [3H]PN200- 110 binding to the
soluble receptor did not change significantly after the first
step of purification, but increased to 8-12 nM, correspond-
ing to a 5-10-fold decrease in affinity for [3H]PN200-1 10,
after the second step of purification (data not shown).
Flockerzi et al. (14, 15) report a similar KD of 10-11 nM
for [3H]PN200-1 10 binding to the purified DHP receptor.
Fig. 2 shows a silver-stained polyacrylamide gel contain-
ing four consecutive sucrose gradient fractions from the
final step of purification. Lanes 2 and 3 contained the peak
of [3H]PN200- 110-labeled receptor (see figure legend for
details). Two prominent polypeptides, with apparent mo-
lecular masses of 170/142 kD and 33 kD, co-migrate with
the labeled receptor (and with the peak of reversible
TALVENHEIMO ET AL. Heterogeneity of Calcium Channels 993
1 2 3 4
170- *
140- .W
51-
33-
-orig
-200
-116
- 97
- 66
- 45
- 29
-dye
FIGURE 2 Purified DHP receptor analyzed by SDS PAGE. The four
consecutive sucrose gradient fractions containing the peak of DHP
binding activity from the final step of purification were individually
lyophilized, dissolved in sample buffer containing 20 mM dithiothreitol,
and boiled. A sample aliquot from each fraction was run in a separate lane
of a 4-15% gradient gel, as described in Methods. Each lane contains 2 ,ug
of protein, but the specific DHP binding activity varied as follows: lane 1,
900 pmol/mg; lane 2, 2,500 pmol/mg; lane 3, 1,940 pmol/mg; lane 4, 500
pmol/mg. The gel was silver-stained according to Oakley et al. (24).
Molecular mass markers (in kilodaltons) were myosin, B-galactosidase,
phosphorylase B, bovine serum albumin, egg albumin, and carbonic
anhydrase.
binding activity). In many preparations, two smaller pep-
tides with apparent molecular masses of 24 and 27 kD
(visible in Fig. 2) also co-migrate with the peak of
[3H]PN200-11O binding activity. In the absence of disul-
fide reducing reagents, the large polypeptide migrates as a
single band with an apparent molecular mass of 170-174
kD (not shown). In the presence of dithiothreitol, the large
polypeptide(s) migrates as a doublet with apparent molec-
ular masses of 142 and 170 kD. Similar results have been
reported by other investigators (5, 12, 28). The 33-kD
polypeptide is similar to the 32-33-kD peptide identified in
purified receptor preparations by other laboratories
(5, 12, 14, 28). A 51-kD peptide also co-migrates with
DHP binding activity. However, the relative amount of this
peptide present in purified DHP receptor samples is vari-
able, possibly due to proteolytic degradation, as suggested
by Curtis and Catterall (12). In the peak receptor fraction
(Fig. 2, lane 2), the 170/142 kD and 33 kD polypeptides
account for 80% of the total silver-staining intensity.
Reconstitution of Functional Calcium
Channels into Planar Lipid Bilayers from
Purified DHP Receptor Preparations
DHP receptor purified to an estimated specific binding
activity of 1,800-2,500 pmol/mg protein was reconstituted
into phospholipid vesicles, then incorporated into pre-
formed planar lipid bilayers by adding the vesicles to one
side of the bilayer, as described in Methods. To optimize
the detection of DHP-sensitive calcium channels, the cal-
cium channel agonist Bay K 8644 was usually added to
both sides of the bilayer.
Contrary to our expectations, two levels of unitary
currents were detected from the purified DHP receptor
preparation. Fig. 3 A shows the two levels of single channel
current fluctuation recorded at two membrane potentials.
Channel openings are indicated by upward deflections.
Traces a and b in Fig. 3 A were selected to show the larger
conductance level at the indicated potentials, while traces c
and d show only the smaller conductance level. These
records were obtained from a single DHP receptor prepa-
ration, purified to a specific activity of 1,800 pmol/mg.
To show that the presence of two sizes of divalent
cation-selective event in the purified receptor preparation
is not an unusual property of the detergent-treated, recon-
stituted protein, channels were also incorporated into
bilayers from intact T-tubule membranes. Fig. 3 B shows a
continuous record of current fluctuations obtained from
intact T-tubule membranes at +95 mV in symmetrical
125 mM BaCl2 solution. This record, which is typical of
records obtained from the intact unpurified membranes,
contains at least two sizes of current fluctuation. Under
these conditions, the larger event has a conductance of -20
pS, and the smaller event has a conductance of 10 pS.
Both types of event are selective for barium over either
sodium or chloride. Thus, at least two divalent cation-
selective conductance levels are detectable in the mem-
brane preparation used as the starting material for purifi-
cation of the DHP receptor.
Current-Voltage Relationships of Purified
Calcium Channels
Fig. 3 C shows the current-voltage relationships obtained
for the two conductance levels incorporated from the
purified DHP receptor preparation. Under the asymmetric
ionic conditions used for these experiments, the I-V rela-
tionships are nonlinear. The positive current measured at 0
mV must be carried by barium ions, and the extrapolated
reversal potentials for both unitary current events is clearly
more negative than - 50 mV, indicating that both types of
event are highly selective for barium over sodium or
chloride. The slope conductance for each channel type was
estimated from the portion of the curve between + 20 and
+ 100 mV. The larger unitary current event has a conduc-
tance of 16 ± 3 pS (80 mM barium), while the smaller
event has a conductance of 7 ± 1 pS (mean ± 95%
confidence limit, n = 4 experiments). These conductance
levels are reasonably close to the conductance levels of the
divalent cation-selective channels from the intact T-tubule
membranes (see also references 1 and 27).
Most of the data plotted in Fig. 3 C were obtained in the
presence of 6 ,uM Bay K 8644 (solid symbols). However,
the same two unitary current levels were observed in the
absence of Bay K 8644 (open symbols), indicating that
Bay K 8644 is not required for the observation of either
type of event and does not affect the observed current
levels. Furthermore, the presence of two single channel
conductance levels is clearly not induced by Bay K 8644.
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FIGURE 3 (A) Purified DHP receptor incorporated into planar lipid bilayers exhibits two conductance levels. DHP receptor purified to a
specific binding activity of 1,800 pmol/mg was incorporated into planar lipid bilayers as described in Methods. The cis compartment
contained 80 mM BaCl2, the trans compartment contained 50 mM NaCl. Bay K 8644 (6 AM final concentration) was added to both sides of
the bilayer. Single channel currents were recorded at the indicated holding potentials. Records a and b were selected to show the larger
conductance level, records c and d, obtained from the same DHP receptor preparation, were selected to show the smaller conductance level. All
records were filtered at 50 Hz. (B) Single channel currents from intact T-tubule membranes incorporated into planar lipid bilayers. Single
channels were incorporated into planar lipid bilayers from intact T-tubule membranes containing 40 pmol/mg DHP receptor as described in
Methods. Symmetric ionic conditions (125 mM BaCI2 cis and trans) were used and Bay K 8644 (6 ,uM final concentration) was added to both
sides of the bilayer. Small conductance events are indicated by arrows. (C) Current-voltage relationships for purified DHP receptor. Single
channel current amplitudes are plotted versus holding potential for both the large conductance level (circles) and the small conductance level
(triangles) exhibited by the purified DHP receptor preparation (1,800 pmol/mg). Ionic conditions were exactly as described for A. Open
symbols (0, v) indicate current levels measured in the absence of Bay K 9644, closed symbols (*, v) indicate current levels measured in the
presence of 6 MuM Bay K 8644 (both sides of the bilayer). The slope conductances, calculated by least squares fit to the data between + 20 mV
and + 100 mV, are 16 ± 3 pS for the larger current level and 7 ± 1 pS for the smaller current level. (D) Cadmium block of the 16 pS
conductance level from purified DHP receptor. Single channel current amplitudes were measured as a function of membrane potential in the
absence (e) and presence (0) of 2.5 mM cadmium (trans side only). Ionic conditions and DHP receptor preparation were identical to those
used in A. 6MgM Bay K 8644 was present on both sides of the bilayer.
Cadmium Block of the 16 pS Purified
Calcium Channel
The sensitivity of the 16 pS conductance level to cadmium
was tested by adding 2.5 mM cadmium to the trans side of
the bilayer. Cadmium reduced the unitary current ampli-
tude by 40%, as shown by the open symbols in Fig. 3 D.
Since the mechanism of cadmium block is proposed to
involve very rapid movement of cadmium on and off a
channel binding site (too rapid to be resolved into discrete
block and unblock events), the predicted effect of cadmium
block is an apparent reduction in the single channel current
amplitude (20). Previous work (3) has shown that 0.4 mM
cadmium reduces the macroscopic calcium current (with
10 mM calcium as the charge carrier) in intact skeletal
muscle by 50%, in accordance with our observation. That
cadmium blocks the 16 pS current fluctuations from
purified DHP receptor preparations supports the identifi-
cation of this channel as a calcium channel.
Nifedipine Inhibition of the 16 pS Purified
Calcium Channel
The effect of the DHP antagonist nifedipine on the proba-
bility of the 16 pS channel being open was measured (Fig.
4, A-C). Symmetrical 100 mM barium solutions contain-
ing 6 uM Bay K 8644 were present on both sides of the
bilayer for this experiment. The left panel of Fig. 4 A
shows a continuous record of channel activity at a holding
potential of -40 mV before the addition of nifedipine.
After 30 min of recording the activity of this channel, 2 ,uM
nifedipine was added to both sides of the bilayer. Within 5
min channel activity decreased dramatically, as indicated
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FIGURE 4 Inhibition of the 16 pS purified calcium channel by nifedipine. (A) Single channel records before and after the addition of 2 AM
nifedipine. DHP receptor purified to a specific binding activity of 2,500 pmol/mg was reconstituted into a planar lipid bilayer. The cis and
trans compartments contained 100 mM BaCl2, and 7 MAM Bay K 8644 was present on both sides of the bilayer. The membrane potential was
held at -40 mV. After control records were obtained, nifedipine was added to both sides of the bilayer to a final concentration of 2 MM, and
recording was resumed 5 min after the drug addition. The records shown were filtered at 100 Hz. (B) Reduction of P(open) by nifedipine. 5
min segments of single channel activity from the experiment shown in A were divided into 100-ms time bins. P(open) was measured and is
plotted for each consecutive bin. (C) Current amplitude histograms before and after the addition of nifedipine. Current amplitudes from the
experiment in A were measured and are shown plotted in a frequency histogram. (D) Increasing concentrations of nifedipine reduce P(open)
of the purified 15-20 pS calcium channel. DHP receptor purified to a specific binding activity of 1,935 pmol/mg was reconstituted into a
planar lipid bilayer. Asymmetric ionic conditions were used: the cis compartment contained 80 mM BaC12, the trans compartment contained
50 mM NaCl, and Bay K 8644 (7 MM) was present on both sides of the bilayer. The membrane potential was held at 0 mV. Nifedipine was
increased from 0 to 3 MM by adding the drug to both sides of the bilayer. Recording was resumed 5 min after each drug addition. The fraction
of time a channel was open was then measured during a 1-min period after each nifedipine addition and is shown plotted versus nifedipine
concentration.
by the record shown in the right panel of Fig. 4 A.
Although the channel continued to open in bursts of
activity, longer periods without activity were observed.
This is illustrated graphically in Fig. 4 B. The experimen-
tal records taken before (left) and after (right) the addition
of nifedipine were divided into sequential 100-ms bins, and
the probability of the channel being open was determined
for each bin, and the results plotted as shown. Nifedipine,
even in the presence of 6 uM Bay K 8644, substantially
decreases the probability of the channel being open.
Fig. 4 C shows the current amplitude histograms
obtained before (top) and after (bottom) the addition of
nifedipine. Nifedipine causes a small reduction in unitary
current amplitude and reduces the fraction of time the
channel spends in the open state from 0.46 to 0.15 (the
relative fraction of time spent in the open and closed states
is proportional to the area under the amplitude histo-
grams). Affolter and Coronado (1) have reported similar
effects of nitrendipine on the kinetics of single calcium
channels from intact T-tubule membranes incorporated
into bilayers. Although the significance of the nifedipine-
induced reduction in single channel conductance was not
analyzed further, this result suggests the interesting possi-
bility that nifedipine modifies the conformation of the open
channel in addition to reducing P(open).
In a separate experiment the effect of increasing concen-
trations of nifedipine on the fractional open time of the 16
pS events was measured at 0 mV in the presence of 7 AM
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Bay K 8644. For this experiment nifedipine was added to
both sides of a bilayer containing a single channel. 5 min
after each nifedipine addition, the fraction of time the
channel was open was measured for 1 min and this is
plotted against nifedipine concentration in Fig. 4 D. The
fractional open time was reduced to 50% of the control by 2
,uM nifedipine. This agrees well with the nitrendipine
inhibition of single calcium channels observed by Affolter
and Coronado (1) and the nifedipine inhibition of calcium
currents in intact muscle fibers (Kj = 0.9 ,M) measured by
Almers and McCleskey (2).
DISCUSSION
The Molecular Composition of the
DHP-binding Protein
We have purified the T-tubule DHP receptor using a
method similar to that used by Curtis and Catterall (12)
and subsequently by Flockerzi et al. (14, 15). The purified
receptor is at least 50% pure with respect to DHP binding
activity, a level comparable to that obtained by Curtis and
Catterall (12) and Flockerzi et al. (15). Two predominant
polypeptides, with molecular masses of 170/142 kD and 33
kD, co-purify with DHP binding activity. The 170/142 kD
polypeptide may in fact represent two distinct polypep-
tides. Three additional peptides, with molecular masses of
51, 27, and 24 kD, are also detectable in the isolated
receptor preparation and appear to co-migrate with the
DHP binding activity. It is not yet clear which of these
peptides are absolutely required for either drug binding
activity or divalent cation transport activity.
The DHP receptor has now been purified from T-tubule
membranes by several laboratories (5, 6, 12, 14, 15).
Although there is substantial agreement on the presence of
at least two polypeptides in the purifed DHP receptor
preparation (170/142 kD and 33 kD), the exact subunit
composition of the receptor has not been conclusively
defined. Curtis and Catterall (12) report that the purified
DHP receptor consists of three polypeptide subunits with
molecular masses of 135, 50, and 33 kD. Borsotto et al.
(5, 6) identified polypeptides with molecular masses of 142
and 32-33 kD in purified DHP receptor preparations, but
did not observe a 50-kD polypeptide. Under some condi-
tions, 29- and 25-kD polypeptides have also been identified
in this preparation (28). Flockerzi et al. (14, 15) recently
reported that the purifed receptor, in addition to 142-, 56-,
and 3 1-kD polypeptides, may also contain 122-, 26-, 22-kD
peptides.
The purified DHP receptor polypeptides retain revers-
ible high affinity DHP binding activity (this paper, and
references 14 and 15), which is allosterically modulated by
verapamil and diltiazem (14), indicating that the purified
polypeptide contains the binding sites for diltiazem and
verapamil as well as for DHPs. Curtis and Catterall (13)
reconstituted the purified receptor, consisting of polypep-
tides with molecular masses of 135, 50, and 33 kD, into
lipid vesicles and demonstrated that this preparation could
promote divalent cation movements. Divalent cation trans-
port was inhibited by PN200-1 10, D600, verapamil, and
inorganic calcium channel antagonists.
Reconstitution of Calcium Channels
from the Purified DHP Preparation
into Planar Lipid Bilayers
We have incorporated purified DHP receptor into planar
lipid bilayers using an approach that was previously used to
incorporate purified brain sodium channels into planar
lipid bilayers (17). We identified divalent cation-selective
channels with conductance levels of 7 and 16 pS (80 mM
barium as the charge carrier) in preparations of purified
DHP binding proteins. Flockerzi et al. (15) have incorpo-
rated purified DHP receptors into bilayers formed on the
tips of patch pipettes and identified a 20 pS divalent
cation-selective channel (in symmetrical 90 mM barium)
from this preparation. The probability of this channel
being open was increased by the DHP agonist Bay K 8644
and was decreased by the phenylalkylamine D600.
We have extended the observations of Flockerzi et al.
(15) in at least two significant ways. In addition to
identifying two divalent cation-selective conductance lev-
els of 7 and 16 pS from the purified DHP receptor
preparation, we demonstrate that the 16 pS calcium
channel can be inhibited by the DHP antagonist nifedi-
pine, and we show that the 16 pS channel is blocked by the
inorganic antagonist cadmium. Moreover, the concentra-
tions of nifedipine and cadmium required to inhibit the
channel are in accordance with both the single channel
data from the intact T-tubules (1) and with macroscopic
calcium current measurements in intact skeletal muscle
(3, 25). These results provide additional support for the
idea that the calcium channels in the bilayer from the
purified preparation are indeed related to the calcium
channels in the intact tissue.
Although the 16 pS calcium channel that we have
identified is similar to the channel identified by Flockerzi
et al. (15) and by Affolter and Coronado (1), it has a single
channel conductance nearly twice that of the DHP-
sensitive calcium channel from skeletal muscle identified
by Rosenberg et al. (27), which had a conductance of 10.6
pS in 110 mM barium. Our results provide a possible
explanation for this apparent discrepancy. We consistently
observe two conductance levels of 7 and 16 pS, either
singly, or together in the same bilayer, from purified DHP
receptor preparations. Skeletal muscle may contain two
distinct types of calcium channel, or alternatively, the
DHP-sensitive calcium channel in skeletal muscle may
exhibit two primary conductance levels. We do not yet
have experimental evidence which would allow us to
distinguish between these alternatives.
In some experiments we observe only one of the two
conductance levels. The experiment shown in Fig. 3, for
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example, lasted for more than 2 h, and during this time we
observed only the 16 pS conductance level. This observa-
tion argues against the conclusion that the two conduc-
tance levels arise from the same molecule. However,
because we do not know what factors might control the
frequency of appearance of different conductance states,
we cannot completely rule out this alternative. It is possi-
ble, for example, that a covalent modification of the
channel molecule determines its conductance level. In this
case, the presence of modified channels in our preparation
would determine which conductance levels we observe, and
these conductance levels would not necessarily be intercon-
vertible under our experimental conditions. Such a possi-
bility is not without precedent; gramicidin channels exhibit
multiple conductance levels. The relative frequencies of
these levels exhibit substantial variation, for reasons that
are not fully understood (8).
We observe single 7 pS channels less frequently than 16
pS channels. There are several possible explanations for
the infrequent appearance of this channel: the 7 pS channel
may not be as abundant as the 16 pS channel in our
preparations, it may not incorporate into bilayers as readi-
ly, or it may open only rarely under our experimental
conditions. The infrequent appearance of this channel and
its small conductance level have made it difficult to test the
effects of antagonists such as cadmium and nifedipine. An
important goal of future experiments is to determine
whether this channel is a DHP-insensitive contaminant in
the DHP receptor preparation. If the 7 and 16 pS channels
are two distinct molecules, the two types of calcium
channel are likely to contain sufficient structural homology
to explain the presence of both channel types in DHP
receptor samples.
Two calcium channel conductance levels in T-tubule
membrane preparations have not been previously
described at the single channel level. However, multiple
conductance levels of single calcium channels have been
described in a variety of other cell types (21, 23, 35).
Moreover, Beam et al. (4) and Cognard et al. (10), using
intracellular recording, have described two components of
macroscopic calcium current in cultured skeletal muscle
cells, a slow DHP-sensitive component, and a fast, tran-
sient DHP-insensitive component. It is possible that the
two conductance levels we have observed from intact
T-tubule membranes underlie the two components of volt-
age-dependent calcium current in skeletal muscle.
The presence of two calcium channel conductance levels
in purified DHP receptor preparations raises two impor-
tant questions regarding the properties of DHP-sensitive
calcium channel. First, as suggested above, a single DHP-
sensitive calcium channel molecule may exhibit multiple
conductance levels, a possibility that has not been ade-
quately explored. Alternatively, the purified DHP receptor
preparation may contain two very closely related, but
distinct, calcium channel molecules. Our results and those
of Flockerzi et al. (15) firmly establish the presence of
functional calcium channels in the purified DHP receptor
preparation. It should be stressed, however, that the single
channels examined in bilayers need not be representative of
the functional state of the purified protein. In fact, the
recent appreciation of the similarities between the pharma-
cology of the "voltage sensors" that couple excitation to
contraction in skeletal muscle and calcium channels has
led to the suggestion that the DHP-binding protein is in
fact this "voltage sensor" (26). Thus, it is possible that
some of the polypeptides that we have purified are in fact
the voltage sensor and that calcium channels have co-
purified with these molecules. The resolution of this prob-
lem depends on the development of more specific biochem-
ical probes for the DHP-sensitive calcium channel poly-
peptides as well as on experiments designed to determine
whether this channel exhibits multiple conductance levels.
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